Course content

A list of the course contents is given on the General strategies in process development for recombinant protein production and purification in different host systems with a special focus  on state of the art methods to improve down-stream process development by implementing design of experiments and quality by design aspects, e.g. in clarification and chromatographic purification. Typical processes will be discussed using real-life equipment and examples.

Learning Outcomes 

Comprehensive insight into the possibilities to conduct and improve process development and scale-up of biomanufacturing processes.

M11  Process development and scale-up of recombinant protein vaccines

Course Goals 

Process development and scale-up of recombinant protein vaccines.


Application Deadline:  

1 July 2021

Course Dates:

Q4 2021 (2 days)


Fraunhofer IME,

Aachen Germany

Participant Nr.: max. 15


Johannes Buyel

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 730964.

Be the first to know about the upcoming application calls, follow European Vaccine Initiative on:

  • LinkedIn Social Icon
  • Twitter Social Icon
Subscribe to TRANSVAC´s Mailing list

© 2020 European Vaccine Initiative. Designed by European Vaccine Initiative